Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vbi Vaccines Inc CS (VBIV)

Vbi Vaccines Inc CS (VBIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vbi Vaccines Inc CS 160 Second Street Floor 3 Cambridge MA 02142 USA

www.vbivaccines.com P: 617-830-3031

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA.

Key Statistics

Overview:

Market Capitalization, $K 1,873
Enterprise Value, $K 28,953
Shares Outstanding, K 28,682
Annual Sales, $ 8,680 K
Annual Net Income, $ -92,840 K
Last Quarter Sales, $ 1,210 K
Last Quarter Net Income, $ -17,900 K
EBIT, $ -72,150 K
EBITDA, $ -68,280 K
60-Month Beta 2.18
% of Insider Shareholders 10.35%
% of Institutional Shareholders 12.26%
Float, K 25,713
% Float 89.65%
Short Volume Ratio 0.50

Growth:

1-Year Return -94.82%
3-Year Return -99.92%
5-Year Return -99.68%
5-Year Revenue Growth 158.33%
5-Year Earnings Growth 86.41%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.55 on 05/15/24
Next Earnings Date 08/12/24
Earnings Per Share ttm -3.10
EPS Growth vs. Prev Year 77.37%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.150 on 12/12/12
Dividend Payable Date 12/28/12
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 04/12/23

VBIV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -525.42%
Return-on-Assets % -45.87%
Profit Margin % -1,069.59%
Debt/Equity -8.91
Price/Sales 0.44
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.19
Interest Coverage -13.51
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar